Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  EntreMed Inc       US29382F2020

SummaryNewsCalendarCompany 
Business Summary
Develops pharmaceutical drugs for treating cancer & inflammatory diseases

CASI Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a new generation of multi-mechanism drugs for the treatment of cancer and inflammatory diseases.

Its drug candidate, ENMD 2076, which is an Aurora A and angiogenic kinase inhibitor for the treatment of cancer.

The company was founded in 1991 and is headquartered in Rockville, MD.

Number of employees : 16 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Therapeutics0.669100%---
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States0.669100%---
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD552012Chief Executive Officer
Wei-Wu He PhD, MBA492012Executive Chairman
Cynthia Wong Hu442006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA442011Chief Accounting Officer & Vice President-Finance
William E. Gannon Jr., MD-2012Vice President-Medical & Regulatory Affairs
Jennie C. Hunter-Cevera, PhD662001Independent Director
Tak W. Mak, PhD672012Director
James Z. Huang, MBA482013Independent Director
Yue Alexander Wu PhD, MBA502013Independent Director
Franklin Cary Salisbury, Jr.-2014Director
Shareholders
NameShares%
IDG Capital Partners Co., Ltd. 6,842,78325.3%
Spectrum Pharmaceuticals, Inc. 5,405,38220.0%
Celgene Corp. 2,464,9879.12%
Wellington Shields Capital Management LLC 775,1552.87%
Wellington Shields & Co. LLC 518,5831.92%
Emerging Technology Partners LLC 441,0721.63%
Kleiner Perkins Caufield & Byers LLC 416,6661.54%
The Vanguard Group, Inc. 391,6601.45%
Tak W. Mak, PhD 365,3761.35%
Cynthia Wong Hu 75,9670.28%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality -
Business Predictability -
PER -
Potential -
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision -
1 year Revenue revision -
More Ratings
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
PHARMACYCLICS, IN..
ALKERMES PLC
PUMA BIOTECHNOLOG..
-
ALNYLAM PHARMACEU..
QUINTILES TRANSNA..
UNITED THERAPEUTI..
QIAGEN NV
ISIS PHARMACEUTIC..
COVANCE INC.
SEATTLE GENETICS,..
TECHNE CORPORATIO..
ICON PLC
PAREXEL INTERNATI..
CHARLES RIVER LAB..
ACADIA PHARMACEUT..
WUXI PHARMATECH (..
SYNAGEVA BIOPHARM..
MORPHOSYS AG
BB BIOTECH AG
Sector Biotechnology & Medical Research
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF